Fonar (FONR) Scheduled to Post Quarterly Earnings on Wednesday

Fonar (NASDAQ:FONR) is scheduled to announce its earnings results before the market opens on Wednesday, February 7th.

Fonar (NASDAQ:FONR) last posted its quarterly earnings results on Thursday, November 9th. The medical equipment provider reported $0.54 earnings per share for the quarter. The company had revenue of $19.33 million for the quarter. Fonar had a net margin of 24.02% and a return on equity of 24.13%.

Fonar (NASDAQ FONR) opened at $23.20 on Tuesday. The firm has a market cap of $154.75, a P/E ratio of 8.41 and a beta of 2.44. Fonar has a one year low of $17.20 and a one year high of $33.90.

A number of large investors have recently bought and sold shares of the business. The Manufacturers Life Insurance Company raised its stake in Fonar by 3,083.6% during the second quarter. The Manufacturers Life Insurance Company now owns 5,635 shares of the medical equipment provider’s stock worth $156,000 after purchasing an additional 5,458 shares during the period. California State Teachers Retirement System purchased a new position in shares of Fonar in the 2nd quarter valued at $300,000. Finally, State Street Corp purchased a new position in shares of Fonar in the 2nd quarter valued at $1,882,000. 45.77% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Fonar (FONR) Scheduled to Post Quarterly Earnings on Wednesday” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/06/fonar-fonr-scheduled-to-post-quarterly-earnings-on-wednesday.html.

About Fonar

Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment.

Earnings History for Fonar (NASDAQ:FONR)

Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply